Clene Inc

CLNN NASDAQ Santé & Biotech États-Unis US1856341029
5.45 $
6.36 %

Entreprise biopharmaceutique engagée dans le développement de traitements utilisant la nanotechnologie pour les maladies neurodégénératives.

Performance & Momentum

6 Months 8.43 %
1 Year 43.28 %
3 Years 72.57 %
5 Years 97.27 %

Similar stocks to Clene Inc

Anantys Community

Be the first to share your analysis on Clene Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases